Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses
Top Cited Papers
Open Access
- 2 April 2024
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (9)
Abstract
The viral kinetics of documented SARS-CoV-2 infections exhibit a high degree of interindividual variability. We identified 6 distinct viral shedding patterns, which differed according to peak viral load, duration, expansion rate, and clearance rate, by clustering data from 768 infections in the National Basketball Association cohort. Omicron variant infections in previously vaccinated individuals generally led to lower cumulative shedding levels of SARS-CoV-2 than other scenarios. We then developed a mechanistic mathematical model that recapitulated 1,510 observed viral trajectories, including viral rebound and cases of reinfection. Lower peak viral loads were explained by a more rapid and sustained transition of susceptible cells to a refractory state during infection as well as by an earlier and more potent late, cytolytic immune response. Our results suggest that viral elimination occurs more rapidly during Omicron infection, following vaccination, and following reinfection due to enhanced innate and acquired immune responses. Because viral load has been linked with COVID-19 severity and transmission risk, our model provides a framework for understanding the wide range of observed SARS-CoV-2 infection outcomes.Keywords
All Related Versions
Funding Information
- National Institute of Allergy and Infectious Diseases (1R01AI177512-01,R01AI121129)
- NIIAID (T32AI118690)
This publication has 69 references indexed in Scilit:
- Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 StrainsJAMA Network Open, 2022
- Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2Antiviral Research, 2022
- Variant‐specific SARS‐CoV‐2 within‐host kineticsJournal of Medical Virology, 2022
- Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including OmicronCell Reports, 2022
- Mechanistic Modeling of SARS‐CoV‐2 and Other Infectious Diseases and the Effects of TherapeuticsClinical Pharmacology & Therapeutics, 2021
- SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19Cancer Cell, 2020
- Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral LoadCPT: Pharmacometrics & Systems Pharmacology, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Within-host mathematical models of hepatitis B virus infection: Past, present, and futureCurrent Opinion in Systems Biology, 2019
- Alternating Host Cell Tropism Shapes the Persistence, Evolution and Coexistence of Epstein–Barr Virus Infections in HumanBulletin of Mathematical Biology, 2010